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Abstract
The etiology of autism spectrum disorder (ASD) is multifactorial and complex and likely involves 
interactions among genetic, epigenetic and environmental factors. With respect to environmental 
influences, a growing literature implicates intrauterine experiences in the origin of this pervasive 
developmental disorder. In this prospective longitudinal design, we examine the hypothesis that 
fetal exposure to maternal cortisol may confer ASD risk. In addition, because ASD is four times 
more prevalent in males than females and because sexually dimorphic responses to intrauterine 
experiences are commonly observed, we examine whether or not any associations differ by fetal 
sex. Maternal plasma cortisol was measured at 15, 19, 25, 31, and 37 weeks’ gestation in a sample 
of 84 pregnant women. ASD symptoms were assessed in their 5-year old children with the Social 
Communication Questionnaire (SCQ). Fetal exposure to lower levels of maternal cortisol was 
associated with higher levels of ASD symptoms among boys only. The observed hypocortisolemic 
profile exhibited by these mothers may indicate a risk factor that precedes the stress of caregiving 
for a child with ASD and may not be solely a consequence of the stress of caregiving as previously 
thought. Further, these findings confirm the value of examining prenatal hormone exposures as 
predictors of ASD risk and support the premise that altered prenatal steroid exposures may play a 
role in the etiology of ASD.
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The Centers for Disease Control and Prevention (CDC) estimates that 1 in 68 children has 
been identified with Autism Spectrum Disorder (ASD), a developmental disability 
characterized by social and communication impairments and repetitive or restricted 
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behaviors and interests (American Psychiatric Association, 2013; Centers for Disease 
Control and Prevention, 2014). ASD is common in all racial, ethnic, and socioeconomic 
groups, and evidence suggests that autism symptoms are continuously distributed across the 
population (Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001; Constantino & 
Todd, 2003; Mulligan, Richardson, Anney, & Gill, 2009; Posserud, Lundervold, & Gillberg, 
2006; Spiker, Lotspeich, Dimiceli, Myers, & Risch, 2002). Although significant advances 
have been made in identifying genetic contributions to this disorder (Abrahams & 
Geschwind, 2008; Hallmayer et al., 2011; Risch et al., 2014; Robinson, Neale, & Hyman, 
2015; Sebat et al., 2007; Trottier, Srivastava, & Walker, 1999), there also is accumulating 
support for significant non-genetic or environmental influences (Durkin et al., 2008; Janecka 
et al., 2017; Lai, Lombardo, & Baron-Cohen, 2014; Landrigan, 2010) and for gene x 
environment interactions (Abbott, Gumusoglu, Bittle, Beversdorf, & Stevens, 2018; Hecht et 
al., 2016; Schaafsma et al., 2017; Tordjman et al., 2014). Among these environmental 
influences, a growing literature implicates intrauterine experiences in the etiology of ASD, 
including obstetric complications and adverse birth phenotype (Atladottir et al., 2010; 
Schendel & Bhasin, 2008), prenatal steroid profiles (Baron-Cohen et al., 2015; Knickmeyer 
& Baron-Cohen, 2006) and prenatal stress exposures (Beversdorf et al., 2005; Class et al., 
2014; Jones et al., 2010; Kinney, Munir, Crowley, & Miller, 2008; Rodriguez & Bohlin, 
2005; Sjaarda et al., 2017; Varcin, Alvares, Uljarevic, & Whitehouse, 2017).
A Potential Role Prenatal Cortisol Exposures in ASD
Here we examine the hypothesis that fetal exposure to maternal cortisol may confer ASD 
risk (Gitau, Adams, Fisk, & Glover, 2005; Gore, Martien, Gagnidze, & Pfaff, 2014; 
Matthews, 2000; Rose’meyer, 2013; Rose’meyer, 2014; Whitaker-Azmitia, Lobel, & Moyer, 
2014). The plausibility of this hypothesis is supported not only by the documentation of 
links between intrauterine stress exposures and ASD risk described above, but also because 
cortisol (the primary glucocorticoid (GC) in humans) has been implicated broadly as a 
principal effector of fetal programming due to its critical role in fetal organ and brain 
development and the fact that it is modulated by stress exposures and environmental 
conditions (Moisiadis & Matthews, 2014; Sandman & Glynn, 2009; Sarkar, Bergman, 
O’Connor, & Glover, 2008; Seckl, 2004; Welberg & Seckl, 2001).
Cortisol in human pregnancy.
Cortisol is a steroid hormone that plays a critical role in normal development and is the end-
product of the hypothalamic-pituitary-adrenal (HPA) axis, one of the body’s major stress 
response systems. HPA axis activity is regulated by the release of hypothalamic 
corticotrophin-releasing hormone (CRH), which stimulates the synthesis and release of 
adrenocorticotropic hormone (ACTH). Release of ACTH from the pituitary into the blood 
stream triggers cortisol production and release from the adrenal cortex. Circulating cortisol 
has effects on nearly every organ and tissue in the body (Munck, Guyre, & Holbrook, 1984). 
During human pregnancy, regulation of the maternal HPA axis changes dramatically with 
the synthesis of CRH from the placenta, beginning as early as the seventh week of gestation 
(Davis & Sandman, 2010; McLean et al., 1995; Sandman & Glynn, 2009). In contrast to the 
role of cortisol in the negative feedback regulation of the HPA axis, cortisol stimulates 
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placental CRH production, resulting in a positive feedback loop that allows for the 
simultaneous increase of CRH, ACTH, and cortisol in both the maternal and fetal 
compartments (King, Nicholson, & Smith, 2001; Petraglia, Florio, Nappi, & Genazzani, 
1996). Over the course of normal gestation, maternal cortisol increases two- to four-fold 
(Mastorakos & Ilias, 2003; Sandman et al., 2006).
Fetal exposure to increasing concentrations of maternal cortisol is regulated by a placental 
enzyme, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which oxidizes cortisol to 
cortisone (Beitins, Bayard, Ances, Kowarski, & Migeon, 1973; Brown et al., 1996). Activity 
of placental 11β-HSD2 increases throughout most of gestation, but because it is only a 
partial barrier, some active maternal cortisol passes through the placenta, resulting in 
significant concordance between cortisol levels in the maternal and fetal compartments 
(Gitau, Cameron, Fisk, & Glover, 1998; Gitau, Fisk, Teixeira, Cameron, & Glover, 2001). 
Prior to parturition, the activity of the 11β-HSD2 decreases, further increasing fetal exposure 
to maternal cortisol (Giannopoulos, Jackson, & Tulchinsky, 1982; Murphy, Smith, Giles, & 
Clifton, 2006). The normative increase in maternal cortisol during gestation coupled with the 
decrease in placental 11β-HSD2 activity at the end of pregnancy ensures that the fetus is 
exposed to sufficient levels of cortisol during the third trimester, which is important for 
maturation of the fetal lungs and other organs (including the brain) and for preparation of the 
fetus for labor and delivery (Austin & Leader, 2000; Hacking, Watkins, Fraser, Wolfe, & 
Nolan, 2001). In addition, these late cortisol exposures have been characterized as 
comprising a critical “switch” necessary for normal brain development (Matthews, 2000). 
We have demonstrated that these heightened exposures late in gestation may be associated 
with salutary effects on brain development (Davis, Head, Buss, & Sandman, 2017; Davis & 
Sandman, 2010).
Altered HPA-axis function among mothers of children with ASD.
Our proposal that fetal exposure to dysregulated maternal cortisol trajectories may confer 
risk for ASD is supported by the fact that aberrant HPA-axis functioning is observed among 
mothers of individuals with ASD. For example, mothers of adolescents and adults with ASD 
exhibit a profile of HPA hypoactivity characterized by a blunted cortisol awakening response 
when compared to mothers of typically developing individuals (Fecteau et al., 2017; Seltzer 
et al., 2010; Wong et al., 2012). Interestingly, this hyporesponsive profile may be more 
pronounced among mothers of children with ASD compared to mothers of children with 
other developmental disabilities. Dykens and Lambert (2013), using group-based trajectory 
analyses, identified two distinctive diurnal cortisol profiles among mothers caring for 
children with ASD and other developmental disabilities − typical and blunted. Eighty-nine 
percent of the mothers of children with ASD fell into the group exhibiting the blunted 
profile, whereas mothers of children with Down syndrome, Prader-Willi syndrome, and 
William’s syndrome were roughly evenly distributed between the two trajectory groups (53 
vs 47%). Because chronic stress has been implicated in dysregulated HPA-axis function 
(Miller, Chen, & Zhou, 2007; Tsigos & Chrousos, 2002), the widely accepted interpretation 
of these findings is that these altered maternal HPA profiles are a consequence of parenting a 
child with a developmental disorder (Bitsika, Sharpley, Andronicos, & Agnew, 2017; Davis 
& Carter, 2008; Rivard, Terroux, Parent-Boursier, & Mercier, 2014; Theule, Wiener, 
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Tannock, & Jenkins, 2010). However, the existing literature has yet to consider the 
possibility that maternal hypocortisolism may represent a biological profile that could confer 
risk for ASD in offspring.
The Current Study
Here with a prospective longitudinal design in which maternal prenatal cortisol profiles 
during gestation were characterized and ASD symptoms in a sample of 5-year old children 
were assessed, we examine whether or not fetal exposures to maternal cortisol are associated 
with child ASD symptoms. Further, because ASD is overrepresented among males (Baron-
Cohen et al., 2011; Lai, Lombardo, Auyeung, Chakrabarti, & Baron-Cohen, 2015; Werling 
& Geschwind, 2013), and sex differences exist in fetal responses to adversity (Bale, 2011, 
2016; Manson, 2008; Sandman, Glynn, & Davis, 2013), including specifically to prenatal 
GC exposures (Adibi et al., 2015; Bale & Epperson, 2015; Glynn & Sandman, 2012; Kim, 
Bale, & Epperson, 2015; Sandman, Davis, Buss, & Glynn, 2011), we test whether the 
relations between prenatal cortisol and ASD symptoms differ based on fetal sex.
Method
Study Overview
Study participants included mother-infant pairs from a longitudinal study of prenatal 
psychobiological risk and development. Women with singleton pregnancies less than 16 
gestational weeks were recruited from obstetric clinics and a large university medical center 
in Southern California. Maternal cortisol was assessed 5 times during pregnancy and child 
ASD symptoms were assessed at 5 years of age.
Participants
The sample comprised 84 mothers and their children (Mage = 5.13, 51.2% female). Initial 
prenatal recruitment criteria included: singleton pregnancy, English speaking, non-smoker, 
over 18 years of age, no use of steroid medication, and no evidence for drug or alcohol use 
during pregnancy. Additional inclusion criteria for this study were that the child had reached 
age 5 during the funded study period. Mothers gave informed consent for all aspects of the 
protocol, which was approved by the Institutional Review Board. The mothers were 27 
percent Latina, 50 percent non- Hispanic white, and 88 percent were married to or 
cohabitating with the child’s father. Fifty percent of the children were first born and the 
mean gestational age at birth was 39.4 weeks (range 35.3 – 42.6 weeks’ gestation). 
Additional descriptive information for the study sample is shown in Table S1 of the 
Supplemental Material available online.
Procedures
Maternal plasma samples were obtained for cortisol analysis at 15 (M = 15.47 ± 0.95), 19 
(M = 19.56 ± 1.09), 25 (M = 25.71 ± 1.08), 31 (M = 31.16 ± 0.88), and 36+ (M = 36.81 ± 
0.90) weeks’ gestation. Mothers completed the Social Communication Questionnaire when 
children were 5 years of age. Maternal reports of ethnicity, age, educational level, income, 
and marital status were collected by structured interview.
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Cortisol assessment.—Maternal blood samples (20 ml/draw) were withdrawn by 
antecubital venipuncture into EDTA (purple top) vacutainers and then immediately chilled 
on ice. Aprotinin (Sigma Chemical, St. Louis, MO) was added at 500 KlU/ml blood. The 
mean sample collection time across study visits was 13:39 hours (range across gestational 
visits: 13:32 to 13:40) and the mean standard deviation of collection time across visits was 
85 minutes (range: 73 to 108 minutes). Samples were centrifuged at 2000 × g for 15 min, 
decanted into polypropylene tubes, and stor2ed at −80°C until assayed.
Plasma cortisol levels were determined by a competitive binding solid-phase enzyme- linked 
immunosorbent assay (IBL Immuno Biological Laboratories America, Minneapolis, MN) 
with reported sensitivity of .22 μg/dl. Plasma samples (20 μl) and enzyme conjugate (200 μl) 
were thoroughly mixed in antibody-coated microtiter wells and incubated at room 
temperature for 60 minutes. Each well was then washed three times with wash solution (400 
μl per well), followed by a 15-min incubation at room temperature with substrate solution 
(100 μl). Absorbance units were measured at 450 nm within 10 minutes of adding stop 
solution. This assay has less than 9% cross-reactivity with progesterone and less than 2% 
cross-reactivity with other naturally-occurring steroid hormones (e.g., testosterone, 
estradiol). All samples were assayed in duplicate. Interassay and intra-assay coefficients of 
variance were less than 8% with a minimum detectable level of .25 μg/dl.
Assessment of autism spectrum disorder symptoms.—Child ASD symptoms 
were assessed using the Social Communication Questionnaire (SCQ) Lifetime version, a 
widely-used, validated parent-report questionnaire based on the Autism Diagnostic 
Interview − Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994). The ADI-R is one of the 
“gold standard” instruments for use in the assessment of ASD. Because the ADI-R is time-
consuming, typically taking 1.5 to 2 hours, and requires a highly trained clinician, the SCQ 
was developed for use as a brief screening tool. The SCQ Lifetime version consists of 40 
binary-scaled questions that evaluate communication skills, social relating, and range of 
interests in children. Item 1 is not scored but is used to determine whether the child has 
enough language to evaluate abnormalities in language. Therefore, scores range from 0–39 
and scores above the cutoff of 15 (sensitivity of 0.85 and specificity of 0.75) suggest the 
individual is likely to have ASD or another neurodevelopmental condition (Rutter, 2003).
Studies examining the distribution of core features of ASD (communication, social 
reciprocal interaction, and restricted/repetitive/stereotyped patterns of behavior) in general 
populations demonstrate that the social deficits characteristic of ASD are common and the 
distribution of these traits continuous (Baron-Cohen et al., 2001; Constantino & Todd, 2003; 
Mulligan et al., 2009; Posserud et al., 2006; Spiker et al., 2002). For use in this study’s 
general community sample, SCQ scores were treated as a continuous variable, an approach 
which is consistent with current emphases on dimensionality and the view that symptom-
based approaches are necessary for clarifying definition and classification of mental 
illnesses (e.g. NIMH Research Domain Criteria (RDoC) project; Calamari, Wiegartz, & 
Janeck, 1999; Constantino, 2011; Cuthbert, 2014; Insel et al., 2010).
Determination of obstetric risk and birth phenotype.—Maternal and infant medical 
records were reviewed to assess pregnancy complications, medication use during gestation 
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and birth outcome. An obstetric risk score accounted for prenatal infection, pregnancy-
induced hypertension, gestational diabetes, oligohydramnios, polyhydramnios, preterm 
labor, vaginal bleeding, placenta previa, and anemia. A cumulative score assessing prenatal 
obstetric risk was derived from the sum of all present risk variables (Hobel, 1982). 
Gestational age at birth (GAB) was calculated using patient report of last menstrual period 
and confirmed with early pregnancy ultrasound according to American Congress of 
Obstetrician and Gynecologists guidelines (American Congress of Obstetricians and 
Gynecologists, 2014).
Statistical analyses.—For primary analyses to assess cumulative fetal exposure to 
maternal cortisol across gestation, an index of maternal prenatal cortisol levels was 
calculated by averaging maternal cortisol levels from each of the five gestational 
assessments. Because cortisol production is affected both by advancing gestation and by 
diurnal rhythms, before averaging, cortisol values were residualized within collection 
timepoint for gestational week and time of day of sample collection. A multiple linear 
regression was performed to examine whether maternal prenatal cortisol levels were 
associated with child ASD symptoms. Demographic (maternal age, maternal race/ethnicity, 
cohabitation with the child’s father, socioeconomic status), pregnancy (obstetric risk, 
gestational age at birth), and child (age, sex, birth order) variables were considered as 
potential covariates (See Table S2 for bivariate correlations with maternal prenatal cortisol 
and child ASD symptoms). Gestational age at birth, socioeconomic status and obstetric risk 
were associated with child ASD symptoms at p < .10 and were therefore included in the 
model. Given well-documented sex differences in the prevalence of ASD (Baron-Cohen, 
Knickmeyer, & Belmonte, 2005; Baron-Cohen et al., 2011; Ingudomnukul, Baron-Cohen, 
Wheelwright, & Knickmeyer, 2007; Knickmeyer & Baron-Cohen, 2006; Nakayama, 
Takahashi, Wakabayashi, Oono, & Radford, 2007) and evidence for sex differences in fetal 
programming (Bale, 2011, 2016; Clifton, 2010; Manson, 2008; Sandman et al., 2013), we 
evaluated fetal sex as a potential moderator of the association between maternal prenatal 
cortisol and child ASD symptoms.
Overall, medication use during gestation in the study sample was low and did not impact 
study findings (See Supplement for details of these analyses).
Secondary analyses were then conducted to examine whether any associations between 
maternal prenatal cortisol levels and child ASD symptoms detected in the regression model 
were dependent on gestational timing. Multilevel modeling (MLM) techniques were utilized 
to examine week-by-week associations between maternal prenatal cortisol levels and child 
ASD symptoms (Raudenbush & Bryk, 2002). HLM offers several advantages over other 
OLS statistical methods for the evaluation of variation over time. First, standard regression 
or ANOVA models are limited to one component of variability, the deviation of the 
individual from the group mean. In comparison, HLM also takes into account the within-
person variability assessed over time. Second, estimates of the lack of fit in modeling each 
individual’s data are derived and the less reliable data are weighted less heavily. Third, HLM 
produces robust estimates despite missing values for the repeated dependent measure. Cases 
with complete data are weighted more heavily, but all cases are included in the estimation of 
effects. Initial testing indicated that a quadratic model best fit maternal prenatal cortisol 
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trajectories and that child ASD symptoms were not associated with linear or quadratic 
change in maternal prenatal cortisol levels over gestation. Therefore, a series of two-level 
models were computed to test differences in maternal prenatal cortisol levels (intercepts) 
centered at 1-week intervals within the range of assessments available (15–37 weeks). Level 
1 (time-variant, within-dyad) variables were maternal prenatal cortisol levels, gestational 
week, gestational week squared, and time of day of sample collection. Level-2 
(timeinvariant, between-dyad) variables were child ASD symptoms and covariates 
(gestational age at birth, socioeconomic status, and obstetric risk).
Results
As expected, a repeated measures ANOVA indicated that maternal plasma cortisol levels 
increased over the course of pregnancy (F(1, 71) = 127.88, p < .001). Average maternal 
gestational cortisol levels did not differ as a function of fetal sex (t = −0.43 – 1.45, p = .15 
− .67). Male (M = 6.73, SD = 3.58) and female (M = 6.47, SD = 4.18) children also did not 
differ in their ASD symptom scores (t = −0.31, p = .76), which is consistent with the 
literature examining distribution of these symptoms and traits in the general population 
(Constantino, 2011; Constantino & Todd, 2003; Mulligan et al., 2009; Ruzich et al., 2015). 
Three participants scored at the clinical cut point for this questionnaire (see Figure S1). 
Further, one male child in the sample had received a clinical diagnosis of ASD and his SCQ 
score was 27. Regression and MLM analyses reported here exclude this individual. See the 
Supplemental Material available online for regression and MLM analyses that do include 
this case.
Regression analyses did not reveal a main effect of maternal prenatal cortisol levels; 
however, the interaction between prenatal maternal cortisol and child sex was statistically 
significant (Table 1). As shown in Figure 1, lower prenatal maternal cortisol levels were 
associated with higher levels of ASD symptoms in boys (slope = −0.45, t = −2.48, p = .01), 
but not in girls (slope = 0.10, t = 0.71, p = .48).
Multilevel modeling indicated that the association between prenatal maternal cortisol levels 
on ASD symptoms in boys did not differ as a function of gestational timing, with 
statistically significant intercept differences present across gestation (Coefficient: −0.35, SE 
= 0.13, t = −2.78, p = .01; see Figure 2).
Discussion
Here we document a link between exposure to lower levels of prenatal maternal cortisol and 
increased manifestation of ASD symptoms in early childhood among boys. Consistent with 
the majority of studies examining prenatal influences on ASD risk, these effects were not 
observed among girls (Baron-Cohen et al., 2011; Harrington, Lee, Crum, Zimmerman, & 
Hertz- Picciotto, 2014; Werling & Geschwind, 2013). These findings also are consistent 
with a number of previous studies documenting hyporesponsive HPA-axis function among 
mothers of individuals with ASD (Dykens & Lambert, 2013; Foody, James, & Leader, 2015; 
Seltzer et al., 2010). Because chronic stress exposures contribute to altered HPA-axis 
function (Kinlein, Wilson, & Karatsoreos, 2015; Miller et al., 2007; Naughton, Dinan, & 
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Scott, 2014), it is not surprising that the prevailing interpretation of the hyporesponsive 
profile exhibited by mothers of children with ASD is that it is due to the significant and 
documented stress associated with caring for a child with a developmental disability (De 
Andres-Garcia, Moya-Albiol, & Gonzalez-Bono, 2012; Dykens & Lambert, 2013; Fecteau 
et al., 2017; Foody et al., 2015; Wong, Mailick, Greenberg, Hong, & Coe, 2014; Wong et al., 
2012). However, the findings presented here raise the possibility of an alternate explanation 
specifically, that causality may run the other way, or at least not be solely due to the stress of 
caregiving. It is important to note that we are not suggesting that among these mothers such 
caregiving does not represent a significant stressor, nor that this chronic stressor does not 
have the potential to influence the HPA-axis function, but rather that altered HPA-axis 
function among these individuals also may represent a marker of offspring ASD risk worthy 
of further consideration. In fact, given that there is significant stability in a woman’s 
endocrine profile (including cortisol) across pregnancies (Fox, Sandman, Davis, & Glynn, 
2015), it is possible, even likely, that this may be one contributing environmental factor that 
promotes concordant sibling phenotypic development. More specifically, the findings here, 
coupled with the intraindividual stability in gestational physiology (Fox et al., 2015), may 
shed light on the observation that there is a higher recurrence risk for ASD among maternal 
compared to paternal half siblings (Gr0nborg, Schendel, & Parner, 2013; Risch et al., 2014).
There are a number of theories that implicate prenatal steroid hormone exposures in the 
etiology of ASD, with a predominate focus on the role of testosterone (Knickmeyer & 
Baron-Cohen, 2006; Pfaff, Rapin, & Goldman, 2011; Rose’meyer, 2013; Whitaker-Azmitia 
et al., 2014). We are aware of only one study that considered prenatal cortisol levels and risk 
for ASD. Baron-Cohen et al. (2015) identified a latent steroidogenic factor in amniotic fluid, 
derived from shared variance in progesterone, 17 α-hydroxy-progesterone, androstenedione, 
testosterone and cortisol, which was elevated among pregnancies resulting in offspring with 
ASD. Because individual hormone levels were not tested, it is not possible to discern the 
unique contributions of cortisol to ASD risk in this cohort. However, our findings, coupled 
with those of Baron-Cohen et al. (2015), confirm the value of examining prenatal hormone 
exposures as predictors of ASD risk and support the premise that altered prenatal steroid 
exposures may contribute to the etiology of ASD.
GCs play a critical role in normal brain development and exert persisting effects on lifespan 
HPA axis function (Davis, Waffarn, & Sandman, 2011; Howland, Sandman, & Glynn, 2017; 
Kapoor, Petropoulos, & Matthews, 2008; Matthews, 2002), which is one reason why they 
have been widely proposed as a central mechanism for programming the fetus (Matthews, 
2000; Trejo, Cuchillo, Machin, & Rua, 2000; Welberg & Seckl, 2001). Most regions of the 
CNS rely on GCs for normal maturation (Challis et al., 2001), and GCs exert these effects by 
initiating terminal maturation, remodeling axons and dendrites and affecting cell survival 
(Gelman, Flores-Ramos, Lopez-Martinez, Fuentes, & Grajeda, 2015; Zunszain, Anacker, 
Cattaneo, Carvalho, & Pariante, 2011). Further, late gestational GC exposures, which are 
facilitated by the drop in 11β-HSD2, provide critical developmental ‘switching’ in the fetal 
brain (Fowden, Li, & Forhead, 1998; Moisiadis & Matthews, 2014).
A prevalent hypothesis suggests that the overrepresentation of neurodevelopmental 
disorders, including ASD, among males may be due in part to sex-specific differences in 
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placental function (Bale, 2011; Davis & Pfaff, 2014; Gabory, Roseboom, Moore, Moore, & 
Junien, 2013; Sandman et al., 2013). The placenta, a transient endocrine organ of fetal 
origin, continually responds to changes in the maternal milieu, with dynamic implications 
for the intrauterine environment. Placental tissue is sex specific, and sexually dimorphic 
responses most likely operate through alterations in gene expression (Graves, 2010; Osei-
Kumah, Smith, Jurisica, Caniggia, & Clifton, 2011), changes in energy mobilization and 
oxygen transport (O’Connell, Moritz, Walker, & Dickinson, 2013) and inflammatory 
responses (Clifton & Murphy, 2004; Reynolds, Vickers, Harrison, Segovia, & Gray, 2015). 
Most directly relevant to the findings here, sex-specific placental responses to GCs have 
been documented (Stark, Wright, & Clifton, 2009). In response to synthetic GC treatment 
for preterm labor, female fetuses exhibit larger increases in placental 11P-HSD2 activity 
compared to males. Male fetuses also may be more vulnerable to a relative lack of cortisol 
because during the third trimester, testosterone concentrations are higher in male 
pregnancies and this could inhibit binding of GCs to their receptors (Da Silva, 1999; 
Simmons, France, Keelan, Song, & Knox, 1994).
Limitations
It is widely accepted that autism has a significant genetic component and it is the case that 
both mothers and individuals with ASD manifest dysregulated HPA-axis function (Dykens 
& Lambert, 2013; Hill, Wagner, Shedlarski, & Sears, 1977; Marinovic-Curin et al., 2008; 
Taylor & Corbett, 2014); therefore, we cannot rule out the possibility that our findings 
reflect a shared genetic vulnerability rather than the consequences of prenatal GC exposures. 
Further, and perhaps more interestingly, emerging research has documented synergistic 
effects between certain genetic profiles and exposures to prenatal stress in determining ASD 
risk (Hecht et al., 2016; Schaafsma et al., 2017). Our study focused narrowly on prenatal 
GCs, and so did not allow consideration of important gene x environment interactions. The 
relatively small sample size comprises a third limitation to the current study. However, our 
confidence in the results of this prospective study is enhanced by the fact that in this sample 
we document three associations that are consistent with other, more well-established 
findings: 1) an association between a hyporesponsive maternal HPA-axis profile and ASD 
among offspring (Dykens & Lambert, 2013; Foody et al., 2015; Seltzer et al., 2010), 2) 
positive associations between adverse birth phenotype, obstetric risk conditions and ASD 
symptoms (Atladottir et al., 2010; Schendel & Bhasin, 2008), and 3) observed sex 
differences revealing a male vulnerability, which is consistent with both the empirical and 
theoretical literature (Baron-Cohen et al., 2011; Werling & Geschwind, 2013). A fourth 
limitation relates to our use of a parent-report screening instrument as the measure of ASD 
symptoms. However, the use of a dimensional instrument to assess symptoms is consistent 
with an RDoC approach and current views advocating the use of dimensional measures to 
advance understanding of ASD (Calamari et al., 1999; Constantino, 2011; Cuthbert, 2014; 
Insel et al., 2010). Further, the distribution of SCQ scores was normal and the observed 
variation is consistent with what would be expected based on use of this and other similar 
instruments administered in the general population (See Figure S1; Constantino & Todd, 
2003; Hoekstra, Bartels, Verweij, & Boomsma, 2007; Mulligan et al., 2009; Posserud, 
Lundervold, & Gillberg, 2009; Wigham, McConachie, Tandos, & Le Couteur, 2012). 
Relatedly, the importance and relevance of these findings for ASD should be considered 
Ram et al. Page 9













with caution in light of the fact that we tested our hypotheses in a general community 
sample. Future research in clinical populations is required to confirm whether prenatal 
cortisol exposures might contribute to the development of this disorder.
Implications
ASD is a heterogeneous condition, characterized by marked variability in clinical 
presentation and biological and behavioral phenotypes (Amaral, 2011; Beversdorf & 
Missouri Autism Summit, 2016; Ellegood et al., 2015; Loth, Murphy, & Spooren, 2016). 
With respect to identification of biomarkers, this unique heterogeneity demands 
identification of ASD subgroups that are more biologically homogeneous, a goal requiring 
novel stratification approaches that are sensitive to developmental stages and timing of 
exposures (Beversdorf & Missouri Autism Summit, 2016; Loth, Spooren, et al., 2016). 
Taken together, our new findings suggest that it might prove fruitful to incorporate prenatal 
GC exposures into approaches aimed at addressing the heterogeneity of this condition and 
also have several broader implications for advancing understanding of the origins of ASD. 
First, they are consistent with the premise that the prenatal period plays a role in determining 
risk for ASD, and that sex differences in the prevalence of developmental disorders such as 
ASD may be due in part to the sexually dimorphic placenta. Second, the fact that we 
observed hyporesponsive HPA-axis profiles among the mothers prior to the birth of their 
children, provides a plausible alternative view of existing literature documenting blunted 
HPA-axis activity in parents of children with ASD. The observed hypocortisolemic profile in 
these mothers may represent a risk factor that precedes the stress of caregiving for a child 
with ASD and not solely a consequence of the stress of caregiving. Further, the findings 
presented here suggest that additional focus should be on pathways related to HPA-axis 
function as well as on the developmental origins of this pervasive developmental disorder.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Association between average prenatal maternal plasma cortisol and child SCQ scores. The 
graph on the left represents this correlation for male children (r = −.45, p = .003). The graph 
on the right represents this correlation for female children (r = .06, p = .70). One male child 
had an ASD diagnosis (left panel, red data point). Including this case in the analyses did not 
alter the association between prenatal cortisol and SCQ scores among males (r = −.42, p 
= .006). Correlations account for both gestational week of sample collection and for time of 
day of collection.
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Maternal gestational plasma cortisol profiles in pregnancies with male fetuses. Mothers of 
boys with low SCQ scores exhibit lower levels of cortisol across pregnancy compared to 
mothers of boys with high SCQ scores. Trajectories of upper and lower quartiles of male 
child SCQ scores derived from the multilevel models are shown for illustrative purposes 
only. All analyses were conducted with SCQ scores as a continuous outcome and with 
adjustment for time of day of sample collection.
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Table 1.
Multiple regression model predicting child ASD symptoms
B (SE) β Partial r
Gestational Age at Birth −0.42 (0.30) −.14 −.16
Obstetric Risk 1.26 (0.69)
.19
† .20
SES −1.18 (0.43) −.28** −.30
Prenatal Cortisol 0.10 (0.13) .10 .09
Child Sex 0.14 (0.77) .02 .02
Prenatal Maternal Cortisol × Child Sex −0.55 (0.21) −.32* −.28
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